OTCMKTS:KMLXF Respiri (KMLXF) Stock Price, News & Analysis $0.0006 0.00 (0.00%) As of 06/29/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Respiri Stock (OTCMKTS:KMLXF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Respiri alerts:Sign Up Key Stats Today's Range$0.0006▼$0.000650-Day Range N/A52-Week Range$0.04▼$0.05VolumeN/AAverage Volume6,100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Respiri (OTCMKTS:KMLXF) is a digital health company focused on empowering patients with respiratory conditions through connected monitoring solutions. The company’s flagship offering, wheezo®, is a compact sensor that attaches directly to a patient’s inhaler, capturing airflow data and wheezing patterns during use. This device syncs with a companion smartphone application, enabling users and healthcare providers to track treatment adherence, symptom trends and early signs of exacerbation in real time. In addition to its inhaler‐based sensor, Respiri operates a cloud‐hosted analytics platform that aggregates patient data for remote monitoring and telehealth integration. The platform generates reports and alerts that clinicians can use to adjust treatment plans, enhance preventive care and reduce the risk of hospital visits. Designed for patients with asthma, chronic obstructive pulmonary disease (COPD) and other respiratory conditions, Respiri’s solution aims to bridge gaps in disease management by offering objective, continuous measurements outside the clinic. Founded in Australia and headquartered in Melbourne, Respiri has secured CE marking for wheezo® and launched commercial operations across Australia, New Zealand and selected European markets. The company continues to pursue regulatory clearances and strategic partnerships to expand its geographic footprint, with a focus on strengthening ties with healthcare providers, pharmacies and research institutions. Through ongoing product development and clinical collaborations, Respiri seeks to establish itself as a leader in home‐based respiratory monitoring and digital therapeutics.AI Generated. May Contain Errors. Read More Receive KMLXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Respiri and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KMLXF Stock News HeadlinesVitasora Health Rebrands and Updates ASX TickerApril 22, 2025 | tipranks.comRespiri Limited Announces Successful Resolutions at General MeetingApril 15, 2025 | tipranks.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.July 2 at 1:00 AM | Stansberry Research (Ad)Respiri Limited Strengthens U.S. Market Position Amid Policy and Trade DevelopmentsApril 8, 2025 | tipranks.comRespiri Limited Proposes Name Change to Vitasora Health LimitedMarch 16, 2025 | tipranks.comRespiri Limited to Hold Virtual General Meeting in April 2025March 16, 2025 | tipranks.comRespiri Limited Announces USA Growth Plans and Major DealsMarch 16, 2025 | tipranks.comRespiri Limited to Unveil U.S. Growth Plans in Upcoming WebinarMarch 13, 2025 | tipranks.comSee More Headlines KMLXF Stock Analysis - Frequently Asked Questions How have KMLXF shares performed this year? Respiri's stock was trading at $0.0581 at the beginning of the year. Since then, KMLXF shares have decreased by 99.0% and is now trading at $0.0006. How do I buy shares of Respiri? Shares of KMLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today7/02/2026Fiscal Year End6/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private Households Sub-IndustryPersonal Services Current SymbolOTCMKTS:KMLXF CIKN/A Webwww.respiri.co Phone61 3 9653 9160Fax61 -0-3 9602 3606EmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.07 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta0.07 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:KMLXF) was last updated on 7/2/2026 by MarketBeat.com Staff. From Our PartnersDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredUrgent exposé on the "Mar-a-Lago Trade"Dr. David Eifrig, former Goldman Sachs VP and Senior Partner at Stansberry Research, has released an urgent ex...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredGold Is About to Do Something It Hasn’t in 90 YearsThe U.S. Treasury still carries America's gold reserves at $42 per ounce — a price set generations ago. Buried...US Gold Bureau | SponsoredWhat Happens to Your Assets If You Die Without a Will?Without a will, your state's intestacy laws decide how your assets are divided — a rigid formula that ignores ...SmartAsset | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Respiri Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Respiri With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.